Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Best-Selling Drugs of 2013
Among the top three disease categories on our list of the top 25 best-selling drugs of 2013, six best-sellers have indications for cancer, four for arthritis, and three for diabetes. Four indications—asthma/COPD, heart disease, HIV, and neurological—are each represented on the list by two best sellers. Have you ever taken any of these drugs?